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Abstract. 
 
ERM (ezrin, radixin, moesin) proteins act as 
linkers between the plasma membrane and the actin cy-
toskeleton. An interaction between their NH
 
2
 
- and 
COOH-terminal domains occurs intramolecularly in 
closed monomers and intermolecularly in head-to-tail 
oligomers. In vitro, phosphorylation of a conserved 
threonine residue (T567 in ezrin) in the COOH-termi-
nal domain of ERM proteins disrupts this interaction. 
Here, we have analyzed the role of this phosphoryla-
 
tion event in vivo, by deriving stable clones producing 
wild-type, T567A, and T567D ezrin from LLC-PK1 epi-
thelial cells. We found that T567A ezrin was poorly as-
sociated with the cytoskeleton, but was able to form oli-
gomers. In contrast, T567D ezrin was associated with 
the cytoskeleton, but its distribution was shifted from 
oligomers to monomers at the membrane. Moreover, 
production of T567D ezrin induced the formation of 
lamellipodia, membrane rufﬂes, and tufts of microvilli. 
Both T567A and T567D ezrin affected the development 
of multicellular epithelial structures. Collectively, these 
results suggest that phosphorylation of ERM proteins 
on this conserved threonine regulates the transition 
from membrane-bound oligomers to active monomers, 
which induce and are part of actin-rich membrane pro-
jections.
Key words: ERM • head-to-tail interaction • confor-
mation • actin • cytoskeleton
 
Introduction
 
ERM (ezrin, radixin, moesin)
 
1
 
 proteins act as linkers be-
tween the plasma membrane and the actin cytoskeleton.
Inactivation studies indicated that these proteins play a
role in the formation of microvilli, cell–cell junctions, and
membrane ruffles, and also regulate substrate adhesion
and motility (Takeuchi et al., 1994; Crepaldi et al., 1997;
Lamb et al., 1997). Regulation of ERM linker function
is thought to occur through conformational changes (Bret-
scher, 1999).
ERM proteins possess two conserved domains. The
NH
 
2
 
-terminal domain is responsible for membrane target-
ing, whereas the COOH-terminal domain contains an
F-actin binding site (Algrain et al., 1993; Turunen et al.,
1994). These two domains interact strongly with each
other, and have been termed N- and C-ERMADs, stand-
ing for ERM association domain (Gary and Bretscher,
1995; Magendantz et al., 1995). In ezrin, N-ERMAD has
been mapped to the first 296 amino acids and C-ERMAD
to the last 107 amino acids. Because of the intramolecular
N/C-ERMAD interaction, most ERM proteins are in a
cytosolic dormant form, in which binding sites for mem-
brane components and F-actin are masked. In the NH
 
2
 
-
terminal domain, cryptic binding sites have been identified
for Rho-GDI and EBP-50 proteins (Reczek et al., 1997;
Takahashi et al., 1997; Reczek and Bretscher, 1998). Re-
cently, the crystal structure of the moesin N-ERMAD
bound to the C-ERMAD revealed a globular conforma-
tion for the N-ERMAD domain and an extended confor-
mation for the C-ERMAD, which mutually mask binding
sites (Pearson et al., 2000).
Intermolecular N/C-ERMAD interactions also form
ERM oligomers. In purified placental microvilli, ezrin
dimers, trimers, tetramers, and higher order oligomers
were identified, suggesting a head-to-tail assembly (Berry-
man et al., 1995). These oligomers are proposed to be as-
sociated with the cytoskeleton and to be involved in mi-
crovillar morphogenesis. However, soluble ezrin dimers
were also detected (Bretscher et al., 1995). Oligomeriza-
tion is not specific to ezrin, since mixed oligomers contain-
ing different ERM members were observed (Gary and
Bretscher, 1993; Andréoli et al., 1994). To engage ERMADs
in intermolecular interactions, cytosolic dormant mono-
mers are thought to be subjected to a gross conformational
change. This phenomenon does not occur spontaneously
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in vitro with purified ezrin, and probably requires an acti-
vation step (Bretscher et al., 1995).
Phosphorylation has been proposed to regulate ERM
activation, since phosphorylation of ERM proteins corre-
lates with their cytoskeletal association (Chen et al., 1994;
Kondo et al., 1998; Simons et al., 1998). Ezrin is phosphor-
ylated on tyrosine residues upon growth factor stimulation
(Gould et al., 1989; Fazioli et al., 1993; Crepaldi et al.,
1997). In response to EGF, ezrin phosphorylation on ty-
rosines 145 and 353 is concomitant with an increase in
dimer formation, suggesting a causal relationship between
phosphorylation and oligomerization (Krieg and Hunter,
1992; Berryman et al., 1995). However, mutations of these
tyrosines into phenylalanines does not alter ezrin localiza-
tion in microvilli, and production of this mutated ezrin
does not affect cell morphology (Crepaldi et al., 1997).
Rather than controlling its cytoskeletal association, ty-
rosine phosphorylation of ezrin appears to transduce sig-
nals. For example, phosphorylation of tyrosine 353 was
found to signal cell survival during epithelial differentia-
tion (Gautreau et al., 1999).
Another phosphorylation site is a better candidate to ac-
tivate ERM cytoskeletal linkage. A phosphothreonine res-
idue, originally identified in moesin (Nakamura et al.,
1995), is localized in a conserved COOH-terminal region
of ERM proteins (T567 in ezrin, T564 in radixin, and T558
in moesin). Using phosphospecific antibodies, this phos-
phorylated residue was detected in ezrin, radixin, and
moesin from a variety of cells and tissues, and phosphory-
lated ERM proteins were shown to be present in actin-rich
membrane structures (Nakamura et al., 1996; Matsui et
al., 1998; Oshiro et al., 1998; Hayashi et al., 1999). Two ki-
nases, protein kinase C-theta (PKC-
 
u
 
) and Rho-kinase,
and two phosphatases, myosin phosphatase and type 2C
protein phosphatase (PP2C), were found in different sys-
tems to regulate the phosphorylation status of this con-
served threonine in ERM proteins (Fukata et al., 1998;
Matsui et al., 1998; Pietromonaco et al., 1998; Hishiya et
al., 1999).
The primary consequence of this phosphorylation event
is to impair N/C-ERMAD interaction. In an overlay as-
say, phosphorylation of T564 in radixin COOH-terminal
domain impairs its association with the NH
 
2
 
-terminal do-
main (Matsui et al., 1998). Similarly, the T558D mutation
of moesin, which mimics the phosphorylated state, was
shown to affect the N/C-ERMAD interaction (Huang et
al., 1999). From the crystal structure, it appears that the
phosphorylation of moesin T558 weakens the N/C-ERMAD
interaction due to both electrostatic and steric effects
(Pearson et al., 2000). The phosphorylation of an isolated
COOH-terminal fragment of ERM proteins does not af-
fect its association with F-actin (Matsui et al., 1998; Huang
et al., 1999). However, in full-length ERM proteins, phos-
phorylation of this conserved threonine is required to bind
to F-actin (Simons et al., 1998; Hishiya et al., 1999; Naka-
mura et al., 1999). These results suggest that phosphoryla-
tion of this residue activates ERM cytoskeletal association
by unmasking the cryptic F-actin binding site. Further-
more, expression of T into D mutant forms of ezrin or
moesin potentiates the formation of microvilli-like dorsal
projections by growth factors (Oshiro et al., 1998; Yone-
mura et al., 1999), whereas transfection of the nonphos-
phorylatable T558A moesin inhibits RhoA-induced for-
mation of these structures (Oshiro et al., 1998; Shaw et al.,
1998).
Although phosphorylation of this conserved threonine
residue regulates the activation of ERM cytoskeletal link-
ers, the mechanism of this regulation is still poorly under-
stood. By disrupting N/C-ERMAD interaction, this phos-
phorylation event could trigger the opening of dormant
monomers, could impair oligomerization, or both. To clar-
ify the mechanism of ERM conformational regulation, we
analyzed the role of ezrin T567 phosphorylation in LLC-
PK1 epithelial cells. We found that T567D ezrin exhibited
a drastic reduction in the amount of oligomers at the
plasma membrane. Monomeric T567D ezrin was associ-
ated with the actin cytoskeleton and induced actin-rich
membrane projections. Production of T567D ezrin strongly
affected epithelial morphology and differentiation. In con-
trast, T567A ezrin exhibited a level of membrane oligo-
mers similar to wild-type (wt), but was poorly associated
with the actin cytoskeleton. These results suggest that
phosphorylation of this conserved threonine regulates a
membrane-specific transition from oligomers to mono-
mers, which are active plasma membrane–actin cytoskele-
ton linkers.
 
Materials and Methods
 
Cells and Recombinant Proteins 
 
LLC-PK1 cells (CCL 101; American Type Culture Collection) were cul-
tured in DME containing 10% FCS and maintained at 37
 
8
 
C in 10% CO
 
2
 
.
Recombinant NH
 
2
 
-terminal fragment 1–309 of ezrin was produced and
purified as a GST fusion as previously described (Gautreau et al., 1999).
GST moiety was cleaved off by thrombin digestion. Recombinant NH
 
2
 
-
terminal fragment was biotinylated with NHS-LC-biotin (Pierce Chemical
Co.) according to the manufacturer’s instructions.
 
cDNA Constructs and Transfection
 
To substitute T567 with A567 or D567, PCR reactions were performed
with oligonucleotides in which the codon ACG was replaced by GCG or
GAC, respectively. The amplified fragments were subcloned into the
pCB6 vector containing VSV G-tagged ezrin cDNA (Algrain et al., 1993).
Myc-tagged ezrin was cloned in pCDNA 3.1 vector (Invitrogen). All PCR
fragments were verified by sequencing.
For transfection, trypsinized cells were resuspended at a concentration
of 2.5 
 
3
 
 10
 
7
 
 cells/ml in 15 mM Hepes, pH 7.4, buffered medium. 200 
 
m
 
l of
cell suspension was added to 50 
 
m
 
l of a solution containing 210 mM NaCl,
5 
 
m
 
g of plasmid DNA, and 30 
 
m
 
g of salmon sperm DNA carrier (Sigma-
Aldrich). LLC-PK1 cells were electroporated with a BioRad Gene Pulser
at 950 
 
m
 
F and 240 V using 4-mm width cuvettes. Transiently transfected
cells were analyzed after 48 h of cDNA expression. Clones producing
T567A and T567D ezrin were established as previously described, and
were compared with the previously obtained clones transfected with the
empty plasmid or producing wt ezrin (Crepaldi et al., 1997).
 
Cytosol/Membrane Fractionation and Gel
Filtration Analysis
 
Cells from a confluent 10-cm dish (for standard immunoprecipitation), or
from ten confluent 10-cm dishes (for the Coomassie blue-stained immuno-
precipitation experiment or gel filtration analysis), were rinsed once with
cold PBS, once with cold cyt buffer (10 mM Hepes, 1 mM EDTA, 150 mM
NaCl, pH 7.4), and scraped off with a rubber policeman in 1 ml of cold cyt
buffer supplemented with protease inhibitors (200 
 
m
 
g/ml pefabloc, 15 
 
m
 
g/
ml benzamidine, 1 
 
m
 
g/ml pepstatin, 1 
 
m
 
g/ml antipain). Cells in suspension
were mechanically disrupted by 10 strokes of a cell cracker. Debris and
nuclei were pelleted by a 10-min centrifugation at 600 
 
g
 
 at 4
 
8
 
C. The super-
natant was then subjected to a 20-min centrifugation at 100,000 
 
g
 
 using a 
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TLA-120.2 rotor in an optima TLX ultracentrifuge (Beckman Coulter).
This ultracentrifugation pellets crude membranes, whereas the superna-
tant is the cytosolic fraction.
For gel filtration analysis, membrane pellets were further extracted by
a 15-min incubation in 200 
 
m
 
l of mbn buffer (10 mM Hepes, 1 mM EDTA,
600 mM KCl, 1% Triton X-100, pH 7.4) supplemented with protease in-
hibitors, and then ultracentrifuged again. 200 
 
m
 
l of cytosol or membrane
extracts were loaded onto a superose-6 HR10/30 gel filtration column
(Amersham Pharmacia Biotech), preequilibrated with cyt or mbn buffer
respectively, and run at a flow rate of 300 
 
m
 
l/min. 250 
 
m
 
l fractions were
collected. The column was calibrated with thyroglobulin, ferritin, aldolase,
and BSA (Sigma-Aldrich) as standards. Thyroglobulin (Stokes radius of
85 Å), ferritin (61 Å), aldolase (48 Å), and BSA (35.5 Å) peaked at frac-
tions 24, 32, 41, and 43, respectively. Void volume of the column emerged
in fraction 3.
When endogenous ERM phosphorylation was examined, cyt and mbn
buffers were also supplemented with 2 mM of sodium pyrophosphate and
1 
 
m
 
M of calyculinA (Upstate Biotechnology). When indicated, LLC-PK1
cells were pretreated for 10 min at 37
 
8
 
C with 300 nM of calyculinA. For
oligomer and monomer samples of Fig. 2, 150 
 
m
 
l of fractions 24–27 and
150 
 
m
 
l of fractions 35–38 were pooled and precipitated by 2 min at 100
 
8
 
C,
followed by 10 min at 4
 
8
 
C. For efficient precipitation of the oligomeric
fraction, 15 
 
m
 
g of BSA was added before boiling, because this fraction
contained a low amount of proteins. The precipitates were pelleted by a
10-min centrifugation at 20,000 
 
g
 
 at 4
 
8
 
C, and resuspended in SDS-loading
buffer.
 
Immunoprecipitations
 
Cytosol or total extracts were adjusted to 1 ml of RIPA buffer (50 mM
Hepes, 10 mM EDTA, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycho-
late, 0.1% SDS, pH 7.4). Membrane pellets were resuspended in RIPA
buffer. RIPA extracts were supplemented with protease inhibitors. For
the experiment in which denatured extracts are used, cells were lysed in 1
ml of 50 mM Hepes, 10 mM EDTA, 150 mM NaCl, 1% NP-40, pH 7.4,
buffer. The extracts were adjusted to 1% SDS and boiled for 2 min. Dena-
tured extracts were then put on ice for 10 min and diluted to 10 ml with a
cold buffer reconstituting RIPA composition.
Extracts were clarified by 10 min centrifugation at 20,000 
 
g
 
 at 4
 
8
 
C, and
incubated with 10 
 
m
 
l of protein A–Sepharose fast-flow beads (Amersham
Pharmacia Biotech) and 5 
 
m
 
g of affinity-purified ezrin or VSV G rabbit
polyclonal antibodies for 2 h (1 ml vol) or overnight (10 ml vol). Beads
were washed five times with 1 ml of RIPA buffer, and boiled 2 min in SDS
loading buffer.
 
Overlay and Western Blotting
 
All blots were performed on nitrocellulose membranes (Protran Hy-
bond). P5D4 anti-VSV G mAb, 9E10 anti-myc mAb, phosphospecific
297S mAb (a kind gift of Dr. S. Tsukita, Kyoto University, Japan), anti-
moesin affinity-purified mouse polyclonal antibodies, anti-radixin affinity-
purified guinea pig polyclonal antibodies (both kind gifts of Dr. P. Mangeat,
University of Montpellier, France), anti-ezrin affinity-purified rabbit poly-
clonal antibodies (Algrain et al., 1993), or biotinylated NH
 
2
 
-terminal domain
of ezrin were used as primary reagents, and alkaline phosphatase-coupled
immunoglobulins or streptavidin, as secondary reagents (Promega). Blots
were developed with nitroblue tetrazolium/5-bromo, 4-chloro, 3-indolyl
phosphate as substrates (Promega). The intensities of bands were quanti-
tated by scanning densitometry on a Bio-Profil station (Vilbert-Lourmat).
 
Immunofluorescence and Microscopy
 
Cell morphology was examined by phase-contrast optics or by Nomarski
optics on a Leica microscope. For scanning EM, cells grown at confluence
on 10-mm 0.2 
 
m
 
m anopore membrane filters (Nunc) were dehydrated in
graded ethanol baths, dried by the critical point method using liquid CO
 
2
 
,
coated with gold palladium, and observed with a JEOL microscope (JSM
840A).
Immunolocalization of exogenous ezrin was achieved with VSV G af-
finity-purified polyclonal antibodies at 10 
 
m
 
g/ml and Cy-2–conjugated goat
anti–rabbit secondary antibodies (Jackson ImmunoResearch Laborato-
ries) on fixed and permeabilized cells using the paraformaldehyde/Triton
X-100 protocol previously described (Crepaldi et al., 1997). Samples were
examined with a Leica confocal laser-scanning microscope, using the same
settings for all acquisitions.
 
Analysis of Cytoskeletal Fraction
 
Confluent cultures from 6 well plates were rinsed quickly with PBS at
room temperature. The soluble fraction was extracted by a 1-min incuba-
tion with 500 
 
m
 
l of a Triton X-100 buffer that preserves cytoskeleton-asso-
ciated material (csk buffer: 50 mM MES, 3 mM EGTA, 5 mM MgCl
 
2
 
, 0.5%
Triton X-100, pH 6.4) at room temperature. For immunofluorescence anal-
ysis, the insoluble material was immediately fixed in 3% paraformalde-
hyde. We verified that actin and microtubule cytoskeletons were not af-
fected by this treatment. For immunoblot analysis, the insoluble material
was quickly rinsed with 500 
 
m
 
l of csk buffer, and further extracted by a
1-min incubation with 500 
 
m
 
l of ice-cold RIPA buffer. When endogenous
ERM phosphorylation was examined, csk and RIPA buffers were also sup-
plemented with 2 mM of sodium pyrophosphate and 1 
 
m
 
M of calyculinA.
 
Development of Multicellular Epithelial Structures
 
For the suspension cyst assay, 25-ml siliconized erlenmeyers containing 5
ml of a cell suspension at 10
 
6
 
 cells/ml in 15 mM Hepes, pH 7.4, buffered
medium were rocked in a shaking incubator at 75 rpm (ROSI 1000; Ther-
molyne). Cultures were analyzed after 48 h. For the tubulogenesis assay,
cells were seeded in a collagen type I gel, as previously described
(Gautreau et al., 1999). 1-wk cultures, in DMEM containing 10% FCS and
100 U/ml of HGF, were examined. Importantly, in these two assays, all
clones isolated in each category behaved similarly.
 
Results
 
T567D Ezrin Exhibits a Low Amount of Oligomers at 
the Membrane
 
We chose to study ezrin function in LLC-PK1 epithelial
cells, which are derived from kidney proximal tubule. This
cell line retains many features of proximal tubule cells,
since it harbors numerous microvilli at its apical surface,
and coexpresses ERM proteins (Berryman et al., 1993). To
analyze the role of ezrin T567 phosphorylation, cDNAs
encoding a nonphosphorylatable variant, T567A ezrin,
and a pseudophosphorylated variant, T567D ezrin, were
expressed in LLC-PK1 cells. We derived stably transfected
clonal cell lines producing wt, T567A, or T567D ezrin,
called E, A, or D cells, respectively, and we compared
them to control clones transfected with the empty plasmid,
called P cells. The exogenous proteins were tagged at the
COOH terminus with a VSV G epitope so they could be
readily distinguished from the endogenous ezrin. The
amount of exogenous ezrin relative to endogenous ezrin
was estimated to be about tenfold higher in the isolated
clones, by immunoblotting serially diluted extracts with
the antiezrin antibody (data not shown).
To assess if the T567D mutation of ezrin impairs the
N/C-ERMAD interaction, we analyzed wt, T567A, and
T567D ezrin for their binding to biotinylated N-ERMAD
in a blot overlay assay. We immunoprecipitated endoge-
nous ezrin or VSV G-tagged ezrin variants from dena-
tured lysates derived from P, E, A, and D cells. This al-
lowed the isolation of ezrin without associated proteins.
An equivalent amount of ezrin and VSV G-tagged wt,
T567A, and T567D ezrin was immunoprecipitated as re-
vealed by ezrin immunoblotting (Fig. 1 A). The endoge-
nous ezrin and VSV G-tagged wt ezrin bound strongly to
the N-ERMAD, indicating that the VSV G tag has little
influence, if any, on the N/C-ERMAD interaction. In con-
trast to wt and T567A ezrin, which bind efficiently to the
ezrin N-ERMAD, the ability of T567D ezrin to interact
with N-ERMAD was substantially diminished. This result 
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suggests that the T567D mutation of ezrin mimics the
phosphorylation of the C-ERMAD, at least in its disrup-
tive effect on the N/C-ERMAD interaction (Matsui et al.,
1998; Huang et al., 1999; Pearson et al., 2000).
In our current view of ERM activation, a discrepancy re-
mains unresolved. On one hand, the active ERM protein,
which is bound to the plasma membrane and the actin cy-
toskeleton, is expected to be oligomeric (Bretscher, 1999).
On the other hand, an ERM protein requires the phosphor-
ylation of this conserved threonine of the COOH-terminal
domain to bind to F-actin (Nakamura et al., 1999). How-
ever, phosphorylation might disrupt the oligomeric form,
through its impairment of intermolecular N/C-ERMAD
interaction. To examine ERM oligomerization, we looked
at whether the ezrin variants were associated with endog-
enous moesin. We immunoprecipitated ezrin from the
membrane pool to enrich for the active form. The immu-
noprecipitates were either stained with Coomassie blue or
immunoblotted with moesin-specific antibodies (Fig. 1 B).
A high amount of ezrin was precipitated with anti-ezrin or
anti-VSV G antibodies, as seen by Coomassie blue stain-
ing. Moesin coprecipitated with endogenous ezrin, exog-
enous wt, and T567A ezrin, but not with T567D ezrin.
This lack of hetero-oligomerization of T567D ezrin with
moesin in the membrane fraction suggests that the T567D
mutation of ezrin impairs intermolecular N/C-ERMAD
interactions. An association with radixin could not be de-
termined, because the immunoprecipitated ezrin gave a
high background at the position of radixin, which migrates
only slightly faster than ezrin in SDS-PAGE.
To examine directly the oligomeric status of T567 mu-
tant forms of ezrin, we used a procedure that resolves
ezrin oligomers from monomers (Berryman et al., 1995).
First, we examined the distribution of endogenous ezrin in
P cells. Ninefold less ezrin is found in the membrane frac-
tion compared with the cytosolic fraction (Table I). Mem-
brane and cytosolic extracts from the P cells were applied
to a superose-6 gel filtration column. Oligomers were de-
tected in the cytosol, as well as in the membrane fraction
(Fig. 2 A). Even if most oligomers were cytosolic (Table
I), the relative level of oligomers over the total ezrin at the
membrane was about twofold that in the cytosol (28% of
oligomers at the membrane vs. 15% of oligomers in the cy-
tosol). Then, we examined the oligomer profile for the
ezrin variants (Fig. 2 A). In the membrane extracts, ezrin
oligomers were observed with wt and T567A ezrin. How-
ever, consistent with its lack of association with moesin,
T567D ezrin from the membrane fraction was eluted es-
sentially as monomers, with only a trace amount of oligo-
mers. Interestingly, in the cytosol, no differences between
ezrin variants were noted. Thus, T567D ezrin exhibited a
strong reduction in the amount of oligomers exclusively at
the membrane.
 
Phosphorylated ERM Proteins Are Preferentially 
Monomeric at the Membrane
 
The analysis of T567D ezrin indicated that the effect of
phosphorylation occurs at the membrane. To get insight
into the distribution of phosphorylated endogenous ERM
proteins from LLC-PK1 cells, we used 297S, an mAb
recognizing this conserved phosphorylated threonine of
ERM COOH-terminal domain (Matsui et al., 1998). We
examined the distribution of phosphorylated ERM pro-
teins between the membrane and the cytosol. When a
similar amount of ERM proteins from total, cytosol, and
membrane fractions was blotted with 297S, phosphory-
lated ERM proteins appeared highly enriched in the
membrane fraction (Fig. 2 B). This result is consistent
with the membrane-dependent effect of the ezrin T567D
mutation.
Because the T567D mutation reduced the amount of
ezrin oligomers at the membrane, we hypothesized that
the phosphorylation of this threonine dissociates ezrin
oligomers into monomers. If this hypothesis is correct,
monomers should be more phosphorylated than oligo-
mers. Our initial attempts to determine which of the
monomers or the oligomers were preferentially phosphor-
ylated failed because of dephosphorylation during the gel
filtration procedure. To overcome this problem, we pre-
treated LLC-PK1 cells with calyculinA, a serine/threonine
protein phosphatase inhibitor known to affect moesin
Figure 1. T567D ezrin has a
reduced N-ERMAD binding
activity in vitro, and does not
oligomerize with moesin
at the membrane in vivo.
Throughout this study,
clones producing VSV
G-tagged wt ezrin, T567A
ezrin, T567D ezrin (E, A,
and D cells, respectively) or
clones obtained after trans-
fection of the empty plasmid
(P cells) were compared. (A)
Denatured extracts from P,
E, A, and D clones were
used to immunoprecipitate
ezrin or VSV G-tagged wt,
T567A, and T567D ezrin. The immunoprecipitates were probed
with ezrin antibodies or with biotinylated ezrin N-ERMAD
(1–309). (B) Ezrin from P, E, A, or D cell membrane extracts was
immunoprecipitated with either anti-ezrin antibodies or anti-VSV
G antibodies as indicated. After SDS-PAGE, the immunoprecip-
itates were stained by Coomassie blue to reveal ezrin (top),
or immunoblotted with moesin-specific antibodies (bottom).
Moesin associated with ezrin can be seen in the Coomassie blue–
stained gel as a faint band just below the strong ezrin band.
 
Table I. Quantification of the Ezrin Content in the
Different Pools
 
Cell debris Cytosol Membrane Membrane ins.
 
%%% %
 
Total 8.8 81.9 9.3 0.057
Monomers – 69.6 6.7 –
Oligomers – 12.3 2.6 –
 
The amount of ezrin was quantified by Western blotting serially diluted fractions. Cells
were mechanically cracked. Cell debris refers to the 600-
 
g
 
 pellet that also contained
nuclei and unbroken cells. The supernatant was then separated by a 100,000-
 
g
 
centrifugation into a cytosolic supernatant and a membrane-containing pellet. The
pellet was extracted with a high salt Triton X-100 buffer. Membrane ins. refers to the
100,000-
 
g
 
 pellet after its extraction (see Materials and Methods). Monomers and
oligomers were separated by gel filtration chromatography and the corresponding
fractions were pooled. These data are the means of two independent fractionations.  
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phosphorylation (Nakamura et al., 1995). This treatment
enhanced the phosphorylation signal and preserved it dur-
ing gel filtration. Consistent with the preferential distribu-
tion of T567D ezrin in the monomeric fraction, ERM
monomers were found to be preferentially phosphorylated
over oligomers (Fig. 2 C).
 
Membrane/Cytosol Distribution of T567D Ezrin Is 
Regulated through its Functional C-ERMAD Domain
 
These results suggest that phosphorylation of ezrin occurs
at the membrane, and dissociates oligomers, through an
impairment of intermolecular N/C-ERMAD interaction at
the membrane. However, we were intrigued by the fact
that T567D ezrin was not defective in cytosolic oligomer-
ization. This result is compatible with the hypothesis that
the C-ERMAD of T567D ezrin is functional for oligomer-
ization in the cytosol, but not at the membrane. To con-
firm in vivo that T567D ezrin has a functional C-ERMAD
in the cytosol, we compared T567D ezrin to 
 
D
 
29 ezrin,
a form in which the 29 COOH-terminal amino acids
were eliminated. Such a deletion completely abrogates
C-ERMAD activity, i.e., N-ERMAD binding (Gary and
Bretscher, 1995; data not shown). We devised a sensitive
assay to study specifically ezrin homo-oligomerization. We
transiently cotransfected LLC-PK1 cells with two ezrin
cDNAs, one of them being tagged by the VSV G epitope,
the other by the myc epitope, and examined the amount of
ezrin–myc coprecipitating with ezrin–VSV G.
We analyzed the distribution of produced proteins be-
tween the membrane and cytosol pools (Fig. 3). Half of
the transfected cell sample was analyzed directly (total),
and the other half was separated in cytosolic and mem-
brane fraction before analysis, so that the three pools were
comparable. In total lysates, similar amounts of wt, T567A,
T567D, and 
 
D
 
29 ezrin were detected. In all transfections, a
Figure 2. T567D ezrin and endogenous phosphorylated ERM
proteins are preferentially monomeric at the plasma membrane.
A, Membrane or cytosolic extracts from P, E, A, and D cells were
resolved by gel filtration chromatography on a superose-6 col-
umn. Fractions 15–41 were analyzed by SDS-PAGE and immu-
noblotted with antiezrin antibodies (P) or anti-VSV G antibodies
(E, A, and D). T567D ezrin exhibited a strongly reduced amount
of oligomers at the membrane, but not in the cytosol. B, Total,
cytosolic, and membrane extracts were immunoblotted with 297S
mAb, recognizing all three ERM proteins when phosphorylated
on this conserved threonine (pERM), or with a mixture of anti-
bodies specific for ERM. Ezrin and radixin comigrated at z80
kD, and moesin migrated at 75 kD. Phosphorylated ERM pro-
teins were strongly enriched in the membrane fraction. C, LLC-
PK1 cells were pretreated with calyculinA, a protein phosphatase
inhibitor, and the membrane extract was resolved by gel filtration
chromatography. Oligomeric and monomeric fractions were
pooled, and immunoblotted as in B. Monomers were preferen-
tially phosphorylated over oligomers.
Figure 3. In the cytosol, T567D ezrin has a functional C-ERMAD.
Various VSV G-tagged cDNAs, wt, T567A, and T567D ezrin, or
an ezrin construct lacking a C-ERMAD due to the deletion of
the 29 COOH-terminal amino acids (D29), were cotransfected
with myc-tagged wt ezrin cDNA into LLC-PK1 cells to detect oli-
gomerization. Total, cytosol, or membrane lysates (top) or VSV
G immunoprecipitates of these lysates (bottom) were analyzed
by immunoblotting with anti-VSV G or anti-Myc antibodies as
indicated on the right of each panel. D29 ezrin was strongly en-
riched in the membrane fraction, and completely defective in oli-
gomer formation. In contrast, T567D ezrin was correctly distrib-
uted between the cytosolic and the membrane fraction, and
exhibited a strongly reduced amount of oligomers specifically at
the membrane. 
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similar amount of ezrin–myc was produced. Analysis of cy-
tosolic and membrane fractions revealed that wt, T567A,
and T567D ezrin were similarly distributed between cyto-
sol and membrane, most of ezrin being in the cytosol. In
contrast, 
 
D
 
29 ezrin was highly enriched in the membrane
fraction. VSV G-tagged proteins were immunoprecipi-
tated, and the immunoprecipitates were analyzed by
immunoblotting with either anti-VSV G or antimyc anti-
bodies. In total lysates, wt, T567A, and T567D ezrin oligo-
merized to roughly the same extent, whereas 
 
D
 
29 ezrin
was completely unable to form oligomers. T567A ezrin ex-
hibited no difference with wt ezrin in its oligomerization
ability in the cytosol and at the membrane. Consistent with
gel filtration analysis, oligomers of T567D ezrin were
present in the cytosol, but only as a trace amount at the
membrane.
These data suggest that a functional C-ERMAD is
needed both to mask membrane binding sites in the NH
 
2
 
-
terminal domain, and to form oligomers. T567D ezrin has
a functional C-ERMAD in the cytosol, since T567D ezrin
forms cytosolic oligomers and is correctly distributed be-
tween the cytosol and the membrane. However, upon
membrane recruitment, the N/C-ERMAD interaction is
abolished by the T567D mutation, and membrane oligo-
mers of T567D ezrin are dissociated.
 
Dramatic Morphological Changes of LLC-PK1 Cells 
Producing T567D Ezrin
 
We asked whether there was a consequence of producing
monomeric T567D ezrin on actin-rich membrane struc-
tures. We examined the morphology of LLC-PK1 clones
producing wt, T567A, or T567D ezrin and the control
clones transfected with the empty plasmid. E clones
formed typical epithelial islets in sparse cell culture (Fig. 4
A), as did A and P clones (data not shown). These islets
were composed of cells adhering to each other. The islet
periphery was regular. In sharp contrast, all the D clones
had an altered morphology. Some space between cells
could be distinguished. The edges of D colonies were
not smooth, but interrupted by wide lamellipodia. Those
lamellipodia were sometimes at the tip of long extensions.
By phase contrast, a refractile relief was also prominent at
the position of the nucleus in most D cells. By scanning
EM, this relief was shown to be due to extensive mem-
brane ruffling (Fig. 4 B).
We observed confluent cultures of P, E, A, and D cells
for optimal epithelial polarization and development of mi-
crovilli. Microvilli containing apical surface of these cells
were analyzed by scanning EM. Production of wt or T567A
ezrin did not alter microvillar density, length or organiza-
tion, which were similar to those of control P cells (Fig. 5).
In these confluent cultures, D cells formed a less organized
layer of cells. The layer of flat cells was often interrupted
by holes that exposed the filter surface, and some round
cells attached above this flat cell layer were frequently ob-
served. We verified that these round structures were in-
deed cells by fluorescent staining of nuclei (data not
shown). Flat cells were covered with microvilli similar to
controls, whereas round cells were covered with denser
and longer microvilli. Occasionally, on the flat cell layer,
microvilli developed aberrantly into tufts (Fig. 5). Such a
tree-like organization of microvilli was never observed in
P, E, or A cultures. In conclusion, production of mono-
meric T567D ezrin in LLC-PK1 cells induces numerous
actin-rich membrane structures, such as lamellipodia, ruf-
fles, and projections that are covered with microvilli.
 
Ezrin Association with the Actin Cytoskeleton Requires 
Phosphorylation of T567
 
Because these ezrin variants displayed differential capac-
ity to affect membrane morphogenesis, we compared their
ability to associate with the actin cytoskeleton. Localiza-
tion of exogenous ezrin by immunofluorescence was per-
formed with anti-VSV G antibodies on confluent cultures
of E, A, and D cells. Wt and T567A ezrin were detected in
microvilli (Fig. 6 A), in a pattern similar to the one of en-
dogenous ezrin in LLC-PK1 cells (data not shown). In the
D cultures, T567D ezrin was found in microvilli of both
flat and round cells and in ruffles. To evaluate whether
these ezrin variants were associated with the actin cyto-
skeleton, we used an extraction procedure with a Triton
X-100 buffer, which preserves the cytoskeleton and cy-
toskeleton-associated proteins. After extraction, wt ezrin
and T567D ezrin were still detected in microvilli. In
sharp contrast, T567A ezrin was almost completely ex-
tracted. Consistently, when Triton X-100 buffer–extracted
Figure 4. Morphology of LLC-PK1 cells producing T567D ezrin.
(A) Clones were examined by phase-contrast optics. P, E, and A
cells grew in typical LLC-PK1 islets (only the E control is pre-
sented). D colonies exhibited a number of morphological
changes. In D colonies, cells were not always adherent to each
other. The periphery of D colonies was irregular with wide lamel-
lipodia (arrowheads). Those lamellipodia were occasionally
formed at the extremity of long extensions (arrow). In most D
cells, the membrane area around the nuclei was highly refractile.
Bar, 25 mm. (B) Scanning EM examination of E and D cell mor-
phology. Extensive membrane ruffling was observed in the cell
central area, probably corresponding to the refractility observed
by phase-contrast optics. Bars: (A) 25 mm; (B) 1 mm. 
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material and cytoskeleton-associated material were com-
pared by immunoblotting, T567A ezrin was highly ex-
tracted (Fig. 6 B). After densitometry of the signals, insol-
uble to soluble ratios were calculated. For exogenous
ezrin, as well as endogenous ezrin, the insoluble pool was
always less than the soluble pool. However, T567A ezrin
was significantly less insoluble than endogenous ezrin, ex-
ogenous wt ezrin, or T567D ezrin (
 
P
 
 , 
 
10
 
2
 
3
 
, ANOVA fol-
lowed by a Bonferroni 
 
t
 
 test). Therefore, T567A ezrin
binds inefficiently to the actin cytoskeleton. Then we ex-
amined the distribution of endogenous phosphorylated
ERM proteins. Consistently, phosphorylated ERM pro-
teins are enriched in the Triton X-100–insoluble fraction.
Taken together, these results indicate that the phosphory-
lation of the C-ERMAD is required for the association of
ERM proteins with the actin cytoskeleton.
 
Effect of T567A and T567D Ezrin on the Development 
of Multicellular Epithelial Structures
 
Organization of the actin cytoskeleton is a crucial point for
the establishment and the maintenance of epithelial polar-
ity. Ezrin has been implicated in the development of multi-
cellular epithelial structures (Crepaldi et al., 1997; Gau-
treau et al., 1999). Therefore, we investigated whether
production of T567A ezrin or T567D ezrin affects the
morphogenesis of LLC-PK1 cells into suspension cysts
and into tubules (Fig. 7).
When isolated LLC-PK1 cells are put in suspension,
they aggregate. These aggregates compact in an epithelial
cyst with a smooth outline (Wohlwend et al., 1985). By two
days, one or several cavities form in these cysts. Cavitation
is a hallmark of the development of epithelial polarity. In
the hollow cyst, the apical pole is in contact with the me-
dium, whereas the basal pole is in contact with the cavity
(Wohlwend et al., 1985). Consistent with the physiology of
kidney proximal tubule, formation of this cavity is thought
to reflect the vectorial transport of solutes and water from
the medium. P, E, and A cells were similarly efficient in
the development of hollow suspension cysts. In contrast to
these cells, D cells were able to aggregate, but remained in
clumps, in which individual round cells could still be distin-
guished at the periphery. Neither compaction nor cavita-
tion occurred in D cells. This suggests that T567D ezrin
impairs the development of epithelial polarity, probably
by inducing constant membrane projections.
Consistent with the morphology of kidney proximal tu-
bule, LLC-PK1 cells are able to develop into elongated
polarized epithelial structures. Tubulogenesis occurs in a
one-week culture in presence of HGF after seeding iso-
lated cells in a three-dimensional collagen type I gel. P
cells were able to differentiate into elongated tubules.
Overproduction of wt ezrin in E cells potentiated this pro-
cess and led to long branched tubules, as we previously re-
ported (Crepaldi et al., 1997). In this sensitive assay for
ezrin function, production of T567A ezrin impaired tubule
formation by affecting clonal growth. By counting cell
number, we observed that colonies formed by A cells were
always composed of less than five cells, instead of tens of
cells for P and E tubules (data not shown). In this assay
also, production of T567D ezrin severely impairs epithelial
organization of colonies. Colonies of D cells developed
into loose aggregates with peripheral cells extending pro-
cesses in the collagen matrix. D colonies never developed
along a well-defined axis. In conclusion, we found that pro-
duction of T567A ezrin affects tubule development, but
Figure 5. Scanning EM analysis of microvilli in clones producing T567A and T567D ezrin. Monolayers of P, E, and A cells exhibited
comparable microvilli in density and length. In D cultures, above a layer of flat cells, which contain comparable microvilli to P, E, and A
cells, some round cells containing numerous and long microvilli were frequently observed. In addition, tufts of microvilli occasionally
emerged from flat D cells (right). Bars, 1 mm. 
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not suspension cyst morphogenesis, whereas production of
T567D ezrin impairs the establishment of epithelial polar-
ity in both assays.
 
Discussion
 
In this report, we have examined in vivo the role of ezrin
T567 phosphorylation by deriving stable clones producing
wt, T567A, and T567D ezrin from the kidney epithelial
cell line, LLC-PK1. Since ezrin is present in microvilli both
as oligomers and as monomers, it was not known whether
the active form of this plasma membrane–actin cytoskele-
ton linker is monomeric or oligomeric (Berryman et al.,
1995; Bretscher, 1999). Our study of T567A and T567D
ezrin suggests that the active ezrin linker is a monomer.
Given the high conservation of this threonine and of the
amino acids forming the interface between the N- and
C-ERMAD in ERM from vertebrates, and in homologues
from invertebrates, the mechanism of conformational acti-
vation by phosphorylation of this conserved threonine from
the C-ERMAD probably applies to all members of the
ERM family (Pearson et al., 2000).
 
The Active Plasma Membrane–Actin Cytoskeleton 
Linker Is a Phosphorylated Monomer
 
T567A ezrin is poorly associated with microvillar cytoskel-
eton, as evidenced by the fact that this variant is almost
completely extracted by a buffer preserving cytoskeleton-
associated material, whereas a significant fraction of wt
ezrin is not. This observation confirms in vivo the recent
finding that phosphorylation of the homologous threonine
558 in moesin is required for F-actin binding in vitro
(Hishiya et al., 1999; Nakamura et al., 1999). Although
T567A ezrin is inactive as a cytoskeletal linker, its level of
oligomers at the membrane is similar to that of wt ezrin.
Thus, the oligomeric species are not sufficient to form ac-
tive linkers.
The T567D mutation mimics the phosphorylation of this
conserved threonine, since both disrupt the N/C-ERMAD
interaction in vitro (our results; Matsui et al., 1998).
In contrast to T567A ezrin, T567D ezrin is associated
with the actin cytoskeleton. Moreover, T567D ezrin is a
strongly morphogenic variant. It triggers the formation of
wide lamellipodia, extensive membrane ruffles, and mi-
crovilli-rich projections, in which T567D ezrin is present.
Figure 6. Ezrin association
with the actin cytoskeleton
requires phosphorylation of
T567. (A) Localization of
ezrin variants with anti-VSV
G antibodies by immunoflu-
orescence and confocal mi-
croscopy in E, A, or D cells.
Cells were also stained af-
ter extraction with a Triton
X-100 buffer that preserves
cytoskeleton-associated ma-
terial (csk). A single apical
section is shown. Wt, T567A,
and T567D ezrin were ob-
served in microvilli. T567D
ezrin was also present in the
membrane ruffles it induced.
After extraction of ezrin-sol-
uble pool, wt and T567D
ezrin staining were pre-
served, whereas T567A ezrin
staining was strongly re-
duced. Bar, 5 mm. (B) West-
ern blot analysis of ezrin
cytoskeletal association.
Similar fractions of soluble
material (Sol), extracted with
the Triton X-100 buffer, and
insoluble material (Ins),
were immunoblotted with
anti-ezrin antibodies for P
cell extract or with anti-VSV
G antibodies for E, A, and D
cell extracts. A densitometric
analysis was performed and
the Ins/Sol ratio was calculated from data obtained from two to four independent experiments with three different A and D clones
(mean 6 SEM). (C) Soluble and insoluble fractions from LLC-PK1 cells were equalized for their ERM content and immunoblotted
with either 297S mAb (pERM) or ERM antibodies. Phosphorylated ERM proteins are enriched in the insoluble fraction. 
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This finding is consistent with T567D ezrin being an active
cytoskeletal linker. By three independent experiments, gel
filtration analysis, assay of ezrin homo-oligomers, and
ezrin-moesin hetero-oligomers, the level of T567D ezrin
oligomers at the membrane was found to be strongly re-
duced. Thus, the oligomeric species are not necessary to
form active linkers. Our study of these two mutant forms
of ezrin, which uncouple oligomerization and cytoskeleton
binding, provides strong evidence that the active form of
this cytoskeletal linker is a phosphorylated monomer.
However, it should be pointed out that phosphorylated ac-
tive ezrin linkers might represent only a minor fraction of
membrane monomers, since T567A ezrin exhibits as high
a level of monomers at the membrane as wt ezrin.
To confirm this finding made with these ezrin variants,
we have analyzed the endogenous phosphorylated ERM
proteins. Consistently, we have found that the phosphory-
lated ERM proteins consist mainly of monomers at the
membrane. Moreover, these phosphorylated ERM pro-
teins are Triton X-100–insoluble, suggesting an association
with the actin cytoskeleton. Therefore, it is likely that the
T567D mutation mimics the phosphorylated state of ezrin
in vivo, as well as in vitro, and thus, represents a useful
tool to study ezrin function.
 
Phosphorylation Impairs N/C-ERMAD Interaction of 
Membrane-bound ERM Proteins
 
Since T567D ezrin shows a strongly reduced level of mem-
brane oligomers and that phosphorylated ERM proteins
are membrane monomers, it is likely that phosphorylation
of this conserved threonine in ERM proteins dissociates
membrane-bound oligomers into active monomers. It is
striking that the phosphorylation-dependent impairment
of N/C-ERMAD interaction occurs only on membrane-
bound molecules, since the T567D mutation affects nei-
ther formation of cytosolic oligomers, nor the correct dis-
tribution between cytosol and membrane. Our in vivo
analysis suggests the following model of ERM activation.
The phosphorylation of a membrane-bound ERM mole-
cule might disrupt intermolecular N/C-ERMAD interac-
tion, thereby dissociating oligomers, and might prevent in-
tramolecular N/C-ERMAD interaction from reforming,
thereby exposing its F-actin binding site.
In vitro, phosphorylated moesin binding to F-actin was
also found to be strongly dependent on the addition of
phosphatidyl-inositol (4,5) bisphosphate or a charged de-
tergent molecule (Nakamura et al., 1999). This result and
our in vivo observations suggest that, for the maintenance
of the active state, N/C-ERMAD interaction should be ab-
rogated by both phosphorylation of the C-ERMAD and
lipid binding to the N-ERMAD. This double regulation of
ERM proteins is highly significant for these plasma mem-
brane–actin cytoskeleton linkers. This double regulation
might also explain that, despite the strong morphogenic ef-
fects of T567D ezrin, no more T567D ezrin than wt ezrin is
Triton X-100–insoluble. This suggests that an activation
factor other than phosphorylation is limiting the amount
of cytoskeleton-bound ezrin. Since inactivation of ERM
linkers occurs presumably through dephosphorylation of
Figure 7. Production of T567A and T567D ezrin affects the development of multicellular epithelial structures. (A) Morphogenesis of
suspension cysts examined by phase-contrast optics. Aggregates of LLC-PK1 cells in suspension are able to form hollow epithelial cysts.
P, E, and A cells were not affected in this process, whereas D cells formed loose aggregates in which individual cells could still be distin-
guished at the periphery. (B) Tubulogenesis assay examined by Nomarski optics. In three-dimensional collagen type I, in the presence
of HGF, P cells are able to differentiate into multicellular tubules. Production of wt ezrin potentiated growth and branching morpho-
genesis of tubules. Production of both T567A and T567D ezrin impaired tubulogenesis. A cells exhibited a growth defect, whereas D
cells grew in disorganized colonies. Bars, 50 mm. 
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this conserved threonine (Fukata et al., 1998; Hishiya et
al., 1999), T567D ezrin might be morphogenic, because, in
contrast to wt ezrin, this variant cannot be dephosphory-
lated. The T567D mutation presumably locks the mem-
brane pool of T567D ezrin in its active conformation.
 
What Is the Role of ERM Oligomers?
 
Since the dormant cytosolic form of ERM proteins is
monomeric and the active plasma membrane–cytoskele-
ton linker is also monomeric, the role of oligomers in the
activation pathway is rather intriguing. Formation of oli-
gomers requires the conformational opening of monomers
and the condensation of two, or more, opened monomers.
The molecular components of the machinery required for
oligomer formation are unknown. Membrane binding sites
are cryptic in the dormant monomer, since a deletion of
the C-ERMAD is sufficient to allow membrane recruit-
ment of 
 
D
 
29 ezrin. This truncated molecule is monomeric,
indicating that oligomerization is not required, per se, for
membrane recruitment. Also intriguing is the observation
that 
 
D
 
29 ezrin, despite having an exposed N-ERMAD,
does not form oligomers, or at least dimers. One possible
explanation is that the machinery for oligomer formation
is only present in the cytosol, and is not accessible to the
membrane-bound 
 
D
 
29 ezrin. Since ezrin oligomers exist in
cytosolic and membrane pools, asymmetric oligomers,
having an exposed N-ERMAD (Bretscher, 1999), might
be in equilibrium between the cytosol and the membrane.
 
Phosphorylation of Ezrin on T567 Transduces 
Morphogenic and Growth Signals
 
ERM proteins are known to be essential for actin-rich
membrane projections (Takeuchi et al., 1994; Crepaldi et
al., 1997; Lamb et al., 1997; Bretscher, 1999). Various stim-
uli that trigger the formation of these membrane struc-
tures induce ERM phosphorylation on this threonine resi-
due (Nakamura et al., 1995; Matsui et al., 1999; Yonemura
et al., 1999). Moreover, we showed that the production of
T567D ezrin in LLC-PK1 cells induces a variety of actin-
rich membrane projections, wide lamellipodia, membrane
ruffling, and projections covered with microvilli, appear-
ing as tufts of microvilli. Therefore, phosphorylation of
this threonine residue on membrane ERM proteins ap-
pears to be critical for the generation of actin-rich mem-
brane projections.
However, it is surprising that the mere production of an
active linker tethering actin cytoskeleton to the plasma
membrane induces such structures. Indeed, these mem-
brane projections require several other coordinated pro-
cesses, such as actin polymerization and cross-linking of
actin filaments. Thus, T567D ezrin, in addition to being an
active linker, induces a complete program for the forma-
tion of lamellipodia and ruffles. This is evidence of signal-
ing events from active ezrin to the machineries controlling
actin polymerization and cross-linking. These constitutive
signaling events from T567D ezrin to actin dynamics and
the consequent formation of membrane projections might
explain why LLC-PK1 cells producing this ezrin variant
fail to achieve epithelial polarity, as seen in suspension
cyst and tubulogenesis assays.
In contrast, production of the inactive linker T567A
ezrin did not affect epithelial polarity, as evidenced by the
development of suspension cysts. In LLC-PK1 cells, pro-
duction of the inactive T567A ezrin does not impair the
formation of epithelial microvilli, whereas in transiently
transfected COS7 cells, T558A moesin was reported to in-
hibit the RhoA-dependent formation of microvilli-like
structures (Oshiro et al., 1998). However, T567A ezrin was
found to be dominant negative in a tubulogenesis assay.
Differentiation of tubules in three-dimensional collagen
matrix in the presence of HGF is a cellular assay critically
dependent on ezrin function. Some phenotypes associated
with expression of wt or mutant ezrin cDNAs are detected
uniquely in these differentiation conditions. As reported
previously, ezrin overproduction potentiates elongation
and branching of tubules (Crepaldi et al., 1997). Produc-
tion of Y353F ezrin specifically triggered apoptosis in this
tubulogenesis assay (Gautreau et al., 1999). Here, produc-
tion of T567A ezrin affected growth of LLC-PK1 cells in
these conditions. One possible mechanism for this domi-
nant negative effect is that overproduced inactive T567A
ezrin is membrane-recruited instead of endogenous ezrin,
and thereby impairs its function. In this tubulogenesis as-
say, phosphorylation of ezrin T567, and activation of its
linker function, are needed for proliferation signaling. In
3T3 cells, T567A ezrin was also found to inhibit Ras- and
Rho-dependent cellular transformation (Tran Quang, C.,
A. Gautreau, M. Arpin, and R. Treisman, manuscript sub-
mitted for publication). How ezrin signals proliferation is
presently not known, but this signaling ability of ezrin re-
lates to the activation of its linker function by phosphor-
ylation of T567.
In the present study, we described the role of ezrin phos-
phorylation on T567 in vivo. This phosphorylation event
regulates a membrane-specific transition of this actin cy-
toskeleton linker from inactive oligomers to active mono-
mers. This unanticipated step of ezrin activation is critical
for cell shape and growth during epithelial differentiation.
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